A unique leather bag crafted from T. rex cells, using biotechnological methods to recreate dinosaur skin in a lab, is set to be auctioned in Paris with an estimated price exceeding $500,000.
A unique leather bag made from T. rex cells failed to meet its reserve price at a Paris auction, with bids falling significantly short of the expected over $500,000.
Non-surgical cosmetic treatments, once associated with wealth and celebrity, are becoming commonplace among ordinary women in Australia, driven by increased accessibility, minimal downtime, and shifting perceptions of beauty and ageing.
Brazil is pioneering lab-grown donkey collagen using precision fermentation to address the global decline in donkey populations driven by demand for China's ejiao medicine. The technology aims to provide a scalable, pure alternative by 2027, reducing animal slaughter and disease risks.
Scientists in Brazil are developing lab-grown donkey collagen to prevent the species' extinction. Professor Carla Molento leads the project, aiming for a pure, scalable product that retains the qualities of conventional collagen without contamination risks.
South Korean scientists have identified a potentially promising new pathway for treating ischemic stroke, long considered one of the most difficult challenges in modern medicine. According to the South Korean team, doctors in China are interested in a partnership and learning more about an experimental drug that it has developed to combat the disease. The team’s study, titled “Oxidative stress-induced astrocytic collagen biosynthesis drives glial barrier formation and neuronal death in ischemic...
Nongshim Co., South Korea's leading instant noodle maker, has partnered with Guangzhou Wanglaoji Pharmaceutical Co. to launch collagen-based dietary supplements in China during the second half of 2026. Under the agreement, Nongshim will sell its Lifill collagen products through the Chinese company's distribution network, while also planning to introduce partner supplements in the Korean market later this year. China's dietary supplements market is valued at approximately 41 trillion won ($27.8 billion), with expected 7% annual growth through 2027.
